Didanosine Adjusted
For wt over 60 kg
Loading...
For wt over 60 kg
References
- P. Fulco. Effect of Tenofovir on Didanosine Absorption in Patients with HIV. Annals of Pharmacotherapy, 2003
- S. Spruance. Didanosine Compared with Continuation of Zidovudine in HIV-infected Patients with Signs of Clinical Deterioration While Receiving Zidovudine. Annals of Internal Medicine, 1994
- T. Grasela. Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine.. The Journal of infectious diseases, 1994
- A. Schindzielorz. Rates and risk factors for adverse events associated with didanosine in the expanded access program.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994
- J. O. Kahn. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.. The New England journal of medicine, 1992
- Eric Singlas. Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis. Antimicrobial Agents and Chemotherapy, 1992